BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 11930688)

  • 1. [Preliminary study on the role of vascular endothelial growth factor in pathogenesis of ovarian hyperstimulation syndrome].
    Zhou C; Yu C; Zhuang G
    Zhonghua Fu Chan Ke Za Zhi; 2001 Nov; 36(11):654-6. PubMed ID: 11930688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Function of vascular endothelial growth factor in ovarian hyperstimulation syndrome].
    Liang W; Chen S; Xing F
    Zhonghua Fu Chan Ke Za Zhi; 2001 Nov; 36(11):651-3. PubMed ID: 11930687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human chorionic gonadotropin-induced ovarian hyperstimulation syndrome is associated with up-regulation of vascular endothelial growth factor.
    Wang TH; Horng SG; Chang CL; Wu HM; Tsai YJ; Wang HS; Soong YK
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3300-8. PubMed ID: 12107240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Follicular fluid levels of vascular endothelial growth factor. Are they predictive markers for ovarian hyperstimulation syndrome?
    Geva E; Amit A; Lessing JB; Lerner-Geva L; Daniel Y; Yovel I; Azem F; Barak V
    J Reprod Med; 1999 Feb; 44(2):91-6. PubMed ID: 10853438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The Predictive Role of Vascular Endothelial Growth Factor and Estradiol in Infertile Patients with Ovarian Hyperstimulation Syndrome].
    Wang Q; Yang G; Yang C; Zhan B; Yang R
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jul; 34(3):565-7. PubMed ID: 12910723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factor levels in serum and follicular fluid of patients undergoing in vitro fertilization.
    Lee A; Christenson LK; Stouffer RL; Burry KA; Patton PE
    Fertil Steril; 1997 Aug; 68(2):305-11. PubMed ID: 9240261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human chorionic gonadotropin-dependent expression of vascular endothelial growth factor/vascular permeability factor in human granulosa cells: importance in ovarian hyperstimulation syndrome.
    Neulen J; Yan Z; Raczek S; Weindel K; Keck C; Weich HA; Marmé D; Breckwoldt M
    J Clin Endocrinol Metab; 1995 Jun; 80(6):1967-71. PubMed ID: 7775647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma levels of soluble vascular endothelial growth factor receptor-1 may determine the onset of early and late ovarian hyperstimulation syndrome.
    Pau E; Alonso-Muriel I; Gómez R; Novella E; Ruiz A; García-Velasco JA; Simón C; Pellicer A
    Hum Reprod; 2006 Jun; 21(6):1453-60. PubMed ID: 16488907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of 'coasting' on follicular fluid concentrations of vascular endothelial growth factor in women at risk of developing ovarian hyperstimulation syndrome.
    Tozer AJ; Iles RK; Iammarrone E; Gillott CM; Al-Shawaf T; Grudzinskas JG
    Hum Reprod; 2004 Mar; 19(3):522-8. PubMed ID: 14998945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in vascular endothelial growth factor levels and the risk of ovarian hyperstimulation syndrome in women enrolled in an in vitro fertilization program.
    Artini PG; Fasciani A; Monti M; Luisi S; D'Ambrogio G; Genazzani AR
    Fertil Steril; 1998 Sep; 70(3):560-4. PubMed ID: 9757891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum inhibin A, VEGF and TNFalpha levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial.
    Babayof R; Margalioth EJ; Huleihel M; Amash A; Zylber-Haran E; Gal M; Brooks B; Mimoni T; Eldar-Geva T
    Hum Reprod; 2006 May; 21(5):1260-5. PubMed ID: 16439507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor, interleukin-6 and interleukin-2 in serum and follicular fluid of patients with ovarian hyperstimulation syndrome.
    Artini PG; Monti M; Fasciani A; Battaglia C; D'Ambrogio G; Genazzani AR
    Eur J Obstet Gynecol Reprod Biol; 2002 Mar; 101(2):169-74. PubMed ID: 11858893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signal mechanisms of vascular endothelial growth factor and interleukin-8 in ovarian hyperstimulation syndrome: dopamine targets their common pathways.
    Chen SU; Chou CH; Lin CW; Lee H; Wu JC; Lu HF; Chen CD; Yang YS
    Hum Reprod; 2010 Mar; 25(3):757-67. PubMed ID: 20008399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular permeability factor and vascular endothelial growth factor in ovarian hyperstimulation syndrome: a preliminary report.
    Krasnow JS; Berga SL; Guzick DS; Zeleznik AJ; Yeo KT
    Fertil Steril; 1996 Mar; 65(3):552-5. PubMed ID: 8774285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Administration of moderate and high doses of gonadotropins to female rats increases ovarian vascular endothelial growth factor (VEGF) and VEGF receptor-2 expression that is associated to vascular hyperpermeability.
    Gómez R; Simón C; Remohí J; Pellicer A
    Biol Reprod; 2003 Jun; 68(6):2164-71. PubMed ID: 12606463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of gonadotropin-releasing hormone antagonists on the expression of vascular endothelial growth factor and its receptors in a rat model of ovarian hyperstimulation syndrome.
    Tong XM; Zhang SY; Song T; Xu WH; Lin XN; Shu J; Liu L
    Chin Med J (Engl); 2008 Dec; 121(23):2434-9. PubMed ID: 19102964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VEGF, IVF clinical variables and ovarian hyperstimulation syndrome: a prospective study of the preimplantation luteal phase.
    Kung FT; Chang SY; Huang FJ; Lan KC
    J Reprod Med; 2007 May; 52(5):365-74. PubMed ID: 17583233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor and its soluble receptor in patients with polycystic ovary syndrome undergoing IVF.
    Artini PG; Ruggiero M; Parisen Toldin MR; Monteleone P; Monti M; Cela V; Genazzani AR
    Hum Fertil (Camb); 2009 Mar; 12(1):40-4. PubMed ID: 19330612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
    J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of serum and follicular fluid cytokine profile in the prediction of moderate to severe ovarian hyperstimulation syndrome.
    Chen CD; Chen HF; Lu HF; Chen SU; Ho HN; Yang YS
    Hum Reprod; 2000 May; 15(5):1037-42. PubMed ID: 10783347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.